Dr Andrzej Rutkowski
While in academia, Andrzej worked in different scientific fields, from oncofoetal antigens to herpes viruses. His projects revolved around changes in gene expression, which is where he developed an array of skills transferrable to biomarker research. While in AstraZeneca, he developed and multiplexed droplet digital PCR assays and used them to monitor cancer-related mutations in […]
Dr Phil Auckland
A chromosome biologist by training, Phil has spent 12 years utilising fluorescence microscopy to visualise molecular processes at the single-cell level. Phil completed his PhD and early postdoctoral studies at Warwick University, where he developed imaging methods to understand the force-generating mechanisms that move chromosomes during cell division. He then moved to Rice University as […]
Dr Rebecca Kelly
Rebecca joined MDC as a postdoctoral scientist in April 2021 following her PhD at the University of Liverpool. Her PhD focused on research into cancer cell migration and invasion using 3D spheroid culture and a range of microscopy modalities, including confocal, TIRF and light sheet. Within the microscopy team, Rebecca specialises in confocal and high-content […]
Dr Martin Main
An ion channel electrophysiologist by training, Martin has spent over 30 years working in the pharmaceutical industry in organisations including Merck, GlaxoSmithKline and AstraZeneca. An accomplished scientist with over 30 publications and 2 patents and a broad range of experience ranging from target validation and reagent generation, through assay development and mechanism-of-action studies, Martin brings […]
Dr Adam Rolt
Adam is a senior scientist within the complex medicines group at MDC. Following a PhD in Chemistry, he carried out postdoctoral positions at the NIH and the University of Oxford, where he was awarded a fellowship and transitioned into a molecular biology role. At MDC, Adam is responsible for the development of novel phenotypic assay […]
Dr Malcolm Haddrick
Malcolm is a Lead Scientist at MDC with 20+ years of experience in diverse Drug Discovery projects for efficacy and safety targets working at Pfizer and AstraZeneca. Malcolm has a PhD from the University of Leicester, followed by a postdoctoral position at the NIH in the USA studying HIV-1 pathogenesis. At MDC, his current role […]
John Vincent
John is a senior scientist with more than 25 years of experience in drug discovery roles, developing biochemical and cellular assays in a range of technologies and formats, utilising an array of laboratory equipment and automation. John has a degree from the University of Nottingham and previously worked for 23 years at AstraZeneca in roles […]
Dr Lorna Fitzpatrick
Lorna is a Lead scientist with 10 years of experience in molecular biology and genetic engineering in primary, stem and cancer cells. Lorna has a PhD from St. George’s University of London and carried out post-doctoral research at Manchester Metropolitan University before joining Medicines Discovery Catapult. In her current role, Lorna develops reporter models of […]
Georgia Smith
For press and media enquiries, contact via: +44 7787 901331 Email: media@md.catapult.org.uk